外科理论与实践 ›› 2019, Vol. 24 ›› Issue (05): 384-386.doi: 10.16139/j.1007-9610.2019.05.003
潘红, 周文斌, 王水
收稿日期:
2019-07-04
出版日期:
2019-10-05
发布日期:
2019-10-05
通讯作者:
王水,E-mail: ws0801@hotmail.com
Received:
2019-07-04
Online:
2019-10-05
Published:
2019-10-05
中图分类号:
潘红, 周文斌, 王水. 腋窝淋巴结转移负荷与乳腺癌前哨淋巴结活检的关系[J]. 外科理论与实践, 2019, 24(05): 384-386.
[1] Fleissig A, Fallowfield LJ, Langridge CI, et al.Post-ope-rative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer[J]. Breast Cancer Res Treat,2006,95(3):279-293. [2] Krag DN, Anderson SJ, Julian TB, et al.Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial[J]. Lancet Oncol,2010,11(10):927-933. [3] Wei S, Bleiweiss IJ, Nagi C, et al.Characteristics of breast carcinoma cases with false-negative sentinel lymph nodes[J]. Clin Breast Cancer,2014,14(4):280-284. [4] Kohl Schwartz AS, Leo C, Rufibach K, et al.Does increased tumor burden of sentinel nodes in breast cancer affect detection procedure?[J]. Eur J Surg Oncol,2013, 39(3):266-272. [5] Goyal A, Douglas-Jones AG, Newcombe RG, et al.Effect of lymphatic tumor burden on sentinel lymph node biopsy in breast cancer[J]. Breast J,2005,11(3):188-194. [6] Zhou W, Zhao Y, Pan H, et al.Great tumour burden in the axilla may influence lymphatic drainage in breast cancer patients[J]. Breast Cancer Res Treat,2016,157(3):503-510. [7] Proulx ST, Luciani P, Christiansen A, et al.Use of a PEG-conjugated bright near-infrared dye for functional imaging of rerouting of tumor lymphatic drainage after sentinel lymph node metastasis[J]. Biomaterials,2013, 34(21):5128-5137. [8] Leijte JA, van der Ploeg IM, Valdes Olmos RA, et al. Visualization of tumor blockage and rerouting of lymphatic drainage in penile cancer patients by use of SPECT/CT[J]. J Nucl Med,2009,50(3):364-367. [9] Wang Y, Zhou W, Li C, et al.Variation of sentinel lymphatic channels (SLCs) and sentinel lymph nodes (SLNs) assessed by contrast-enhanced ultrasound(CEUS) in breast cancer patients[J]. World J Surg Oncol,2017,15(1):127-133. [10] Suga K, Yuan Y, Okada M, et al.Breast sentinel lymph node mapping at CT lymphography with iopamidol: preliminary experience[J]. Radiology,2004,230(2):543-552. [11] Galimberti V, Cole BF, Zurrida S, et al.Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial[J]. Lancet Oncol,2013,14(4):297-305. [12] Giuliano AE, Ballman KV, McCall L, et al. Effect of axillary dissection [13] Dengel LT, Van Zee KJ, King TA, et al.Axillary dissection can be avoided in the majority of clinically node-negative patients undergoing breast-conserving therapy[J]. Ann Surg Oncol,2014,21(1):22-27. [14] Donker M, van Tienhoven G, Straver ME, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial[J]. Lancet Oncol,2014,15(12):1303-1310. [15] Gentilini O, Veronesi U.Staging the axilla in early breast cancer: will imaging replace surgery?[J]. JAMA Oncol,2015,1(8):1031-1032. [16] Boughey JC, Suman VJ, Mittendorf EA, et al.Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial[J]. JAMA,2013,310(14):1455-1461. [17] Kuehn T, Bauerfeind I, Fehm T, et al.Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study[J]. Lancet Oncol,2013,14(7):609-618. [18] Caudle AS, Yang WT, Krishnamurthy S, et al.Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective eva-luation of clipped nodes: implementation of targeted axillary dissection[J]. J Clin Oncol,2016,34(10):1072-1078. |
[1] | 张小丽 李赞 宋达疆 王业成 海涛. 带蒂胸外侧动脉穿支皮瓣在保乳术后即刻乳房重建中的临床应用[J]. 组织工程与重建外科杂志, 2022, 18(5): 382-. |
[2] | 宋达疆 李赞 章一新. 带蒂腹直肌皮瓣联合游离腹壁下动脉穿支皮瓣移植重建胸壁巨大缺损的手术策略[J]. 组织工程与重建外科杂志, 2022, 18(5): 386-. |
[3] | 姚成才 陈明 刘长春 黄传蔷 冼家仪 严国标 陈庞洲. 硅凝胶乳房假体联合钛网补片在早期乳腺癌即刻乳房重建中的应用[J]. 组织工程与重建外科杂志, 2022, 18(3): 247-. |
[4] | 廖晓明 蒋奕 唐玮 杨华伟 姬逸男 韦莉颖. 薄层血管化腹股沟淋巴结皮瓣移植联合反向淋巴显影在继发性上肢淋巴水肿手术中的应用[J]. 组织工程与重建外科杂志, 2022, 18(1): 8-. |
[5] | 宋景涌 汤鹏 钟晓捷 刘侠 孙洋 亢玉 王遥佳 陈安玥 陈怡安 吉训通 周艳虹 蒋曼妃 修骋 穆籣. 吻合口通畅性量化分析应用于乳腺癌腋窝淋巴结清扫术同期预防性淋巴管静脉吻合1例[J]. 组织工程与重建外科杂志, 2022, 18(1): 34-. |
[6] | 陈小松, 沈坤炜, 李宏为. 早期可手术乳腺癌的诊治现状与展望[J]. 外科理论与实践, 2022, 27(05): 385-386. |
[7] | 吴佳毅, 陆裕杰, 何金光, 沈坤炜, 徐华. 乳腺癌术后植入物乳房重建技术[J]. 外科理论与实践, 2022, 27(05): 387-391. |
[8] | 陈益定, 吴世杰. 遗传性乳腺癌外科治疗[J]. 外科理论与实践, 2022, 27(05): 392-395. |
[9] | 谢妍妍, 吕青, 杜正贵. 乳腺腔镜和机器人手术的现状及未来之路——华西医院经验分享[J]. 外科理论与实践, 2022, 27(05): 396-402. |
[10] | 周文斌, 唐新宇, 王水. 局部微波消融技术在乳腺癌治疗中的应用[J]. 外科理论与实践, 2022, 27(05): 403-405. |
[11] | 曹璐, 郑思悦, 陈佳艺. 早期乳腺癌区域淋巴结局部处理[J]. 外科理论与实践, 2022, 27(05): 406-410. |
[12] | 黄蔚, 李恒宇, 丁晓毅. 晚期乳腺癌介入诊疗的价值及应用[J]. 外科理论与实践, 2022, 27(05): 411-415. |
[13] | 舒兰, 陈小松. ER+/HER2-乳腺癌多基因阵列检测应用:ASCO指南解读与瑞金医院临床实践[J]. 外科理论与实践, 2022, 27(05): 416-420. |
[14] | 杨崔燕, 王豪雨, 陈小松, 沈坤炜. 抑癌基因TP53突变状态与三阴性乳腺癌病人预后的研究[J]. 外科理论与实践, 2022, 27(05): 421-428. |
[15] | 潘睿忻 综述, 陈小松, 沈坤炜 审校. 循环肿瘤DNA和循环肿瘤细胞检测乳腺癌微小残留病灶的研究[J]. 外科理论与实践, 2022, 27(05): 463-467. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||